Re:3D has moved onto the next phase of a NSF program focused on circular economy innovation. Photo via re3d.org

An innovative project led by Houston-founded re:3D Inc. is one of six to move forward to the next phase of the National Science Foundation's Convergence Accelerator that aims to drive solutions with societal and economic impact.

The sustainable 3D printer company will receive up to $5 million over three years as it advances on to Phase 2 of the program for its ReCreateIt project, according to a statement from the NSF. Co-funded by Australia's national science agency, the Commonwealth Scientific and Industrial Research Organisation, or CSIRO, ReCreateIt enables low-income homeowners to design sustainable home goods using recycled plastic waste through 3D-printing at its net-zero manufacturing lab.

The project is in partnership with Austin Habitat for Humanity ReStores and researchers from the University of Wollongong and Western Sydney University. CSIRO is funding the Australian researchers.

In Phase II the teams will receive training on product development, intellectual property, financial resources, sustainability planning and communications and outreach. The goal of the accelerator is to promote a "circular economy," in which resources are reused, repaired, recycled or refurbished for as long as possible.

"Progress toward a circular economy is vital for our planet's health, but it is a complex challenge to tackle," Douglas Maughan, head of the NSF Convergence Accelerator program, said in the statement. "The NSF Convergence Accelerator program is bringing together a wide range of expertise to develop critical, game-changing solutions to transition toward a regenerative growth model that reduces pressure on natural resources, creates sustainable growth and jobs, drastically reduces waste and ultimately has a positive impact on our environment and society. Phase 2 teams are expected to have strong partnerships to ensure their solutions are sustained beyond NSF support."

Other teams that are moving forward in the accelerator include:

  • FUTUR-IC: A global microchip sustainability alliance led by MIT
  • PFACTS: Led by IBM's Almaden Research Center and aiming to replace, redesign and remediate fluorine-containing per- and polyfluoroalkyl substances (PFAS)
  • SOLAR: A team led by Battelle Memorial Institute using photovoltaic circularity to develop the technology needed to achieve sustainable solar recycling
  • SpheriCity: A cross-sector tool that examines how plastics, organics and construction and demolition materials flow through local communities developed by the University of Georgia Research Foundation Inc.
  • Topological Electric: Another MIT-led team, this group aims to develop electronic and energy-harvesting device prototypes based on topological materials.

Re:3d and 15 other teams were first named to the Convergence Accelerator in 2022 with a total investment of $11.5 million. At the end of Phase 1, the teams participated in a formal Phase 2 proposal and pitch, according to the NSF. The Convergence Accelerator was launched in 2019 as part of the NSF's Directorate for Technology, Innovation and Partnerships.

This is the latest project from re:3D to land national attention and funding. Last year the company was one of 12 to receive up to $850,000 from NASA's SBIR Ignite pilot for its project that aimed to develop a recycling system that uses a 3D printer to turn thermoplastic waste generated in orbit into functional and useful objects, according to the project's proposal.

In 2022, it was also among the winners of an inaugural seed fund expo from the U.S. Small Business Administration. It also earned the prestigious Tibbetts Award from the SBA in 2021. The award honors small businesses that are at the forefront of technology.

Re:3D Inc. was founded in 2013 by NASA contractors Samantha Snabes and Matthew Fiedler and is based in Clear Lake. It's known for its GigaBot 3D printer, which uses recycled materials to create larger devices. The company announced its new Austin headquarters earlier this year.
Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Nominations are now open for the 2025 Houston Innovation Awards

Calling All Innovators

Calling all Houston innovators: The Houston Innovation Awards return this fall to celebrate the best and brightest in the Houston innovation ecosystem right now.

Presented by InnovationMap, the fifth annual Houston Innovation Awards will take place November 5 at TMC Helix Park.

The awards program will honor the top startups and innovators in Houston across 10 categories, and we're asking you to nominate the most deserving Houston innovators and innovative companies today.

This year's categories are:

  • Minority-founded Business, honoring an innovative startup founded or co-founded by BIPOC or LGBTQ+ representation.
  • Female-founded Business, honoring an innovative startup founded or co-founded by a woman.
  • Energy Transition Business, honoring an innovative startup providing a solution within renewables, climatetech, clean energy, alternative materials, circular economy, and beyond.
  • Health Tech Business, honoring an innovative startup within the health and medical technology sectors.
  • Deep Tech Business, honoring an innovative startup providing technology solutions based on substantial scientific or engineering challenges, including those in the AI, robotics, and space sectors.
  • Startup of the Year (People's Choice), honoring a startup celebrating a recent milestone or success. The winner will be selected by the community via an interactive voting experience.
  • Scaleup of the Year, honoring an innovative later-stage startup that's recently reached a significant milestone in company growth.
  • Incubator/Accelerator of the Year, honoring a local incubator or accelerator that is championing and fueling the growth of Houston startups.
  • Mentor of the Year, honoring an individual who dedicates their time and expertise to guide and support budding entrepreneurs.
  • Trailblazer, honoring an innovator who's made a lasting impact on the Houston innovation community.

Nominations may be made on behalf of yourself, your organization, and other leaders in the local innovation scene. The nomination period closes on August 31, so don't delay — nominate today at this link, or fill out the embedded form below.

Our panel of esteemed judges will review the nominations, and determine the finalists and winners. Finalists will be unveiled on September 30, and the 2025 Houston Innovation Awards winners will be announced live at our event on November 5.

Tickets will go on sale this fall. Stay tuned for that announcement, as well as more fanfare leading up to the 2025 Houston Innovation Awards.

Nominate now:

Interested in Innovation Awards sponsorship opportunities? Please contact sales@innovationmap.com.

MD Anderson launches $10M collaboration to advance personalized cancer treatment tech

fighting cancer

The University of Texas MD Anderson Cancer Center and Japan’s TOPPAN Holdings Inc. have announced a strategic collaboration to co-develop TOPPAN Holdings’ 3D cell culture, or organoid, technology known as invivoid.

The technology will be used as a tool for personalized cancer treatments and drug screening efforts, according to a release from MD Anderson. TOPPAN has committed $10 million over five years to advance the joint research activities.

“The strategic alliance with MD Anderson paves a promising path toward personalized cancer medicine," Hiroshi Asada, head of the Business Innovation Center at TOPPAN Holdings, said in a news release.

Invivoid is capable of establishing organoid models directly from patient biopsies or other tissues in a way that is faster and more efficient. Researchers may be able to test a variety of potential treatments in the laboratory to understand which approach may work best for the patient, if validated clinically.

“Organoids allow us to model the three-dimensional complexity of human cancers in the lab, thus allowing us to engineer a powerful translational engine—one that could not only predict how patients will respond to therapy before treatment begins but also could help to reimagine how we discover and validate next-generation therapies," Dr. Donna Hansel, division head of pathology and laboratory medicine at MD Anderson, added in the news release. “Through this collaboration, we hope to make meaningful progress in modeling cancer biology for therapeutic innovation.”

The collaboration will build upon preclinical research previously conducted by MD Anderson and TOPPAN. The organizations will work collaboratively to obtain College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) certifications for the technology, which demonstrate a commitment to high-quality patient care. Once the certifications are obtained, they plan to conduct observational clinical studies and then prospective clinical studies.

“We believe our proprietary invivoid 3D cell culture technology, by enabling the rapid establishment of organoid models directly from patient biopsies, has strong potential to help identify more effective treatment options and reduce the likelihood of unnecessary therapies,” Asada added in the release. “Through collaboration on CAP/CLIA certification and clinical validation, we aim to bring this innovation closer to real-world patient care and contribute meaningfully to the advancement of cancer medicine."